Doctors used data collected by a Fitbit Charge HR to decide whether to reset a patient's heart rate with electrical cardioversion
This Dude's Fitness Tracker May Have Just Saved His Life — A 42-year-old man from New Jersey recently showed up in an emergency ward following a seizure.
Context & Ripple Effects
This case lands mid-controversy: months earlier, the Fitbit Charge HR's heart-rate sensor was the subject of a class-action lawsuit over accuracy, until independent retests had it passing handily. A New Jersey emergency team then leaned on that same consumer device's data to decide whether to electrically reset a patient's heart — a use far beyond anything Fitbit marketed the band for.
First-order effects
- The treating physicians gained a continuous heart-rate record at the bedside that no prescribed clinical monitor was providing, and used it to commit to electrical cardioversion.
- For Fitbit, an ad-hoc life-critical use of the Charge HR is a credibility windfall arriving just as the accuracy lawsuit threatened the product's reputation.
Second-order effects
- Fitbit moved to make this accidental workflow official, opening its data to clinicians through Google's Cloud Healthcare API so doctors could monitor devices routinely rather than read one-off screenshots.
- Rival Apple pushed the same direction with watch-based diagnostics, and by 2024 doctors were reportedly using the Apple Watch to manage conditions even where approved medical devices existed.
Third-order effects
- Regulators formalized what ERs were already doing informally: Fitbit received FDA clearance for passive AFib detection in 2022, converting a wellness accessory into a cleared screening device.
- If the pattern holds, the boundary between consumer wearables and regulated medical hardware keeps eroding, with consumer-device makers competing for the clinical workflows that dedicated monitoring vendors once owned.
The trend: Consumer fitness trackers are being pulled from wellness accessories into clinical decision-making, with FDA clearances retroactively legitimizing uses doctors pioneered at the bedside.